If you need more lookups,
subscriptions start at $34 USD/month.
Thomas Knapp Location
Washington, DC, US
Thomas Knapp Work
2019 -now SVP, General Counsel @ Ascentage Pharma Group
2019 -2021 SVP, General Counsel @
2018 -2021 SVP, Legal Affairs @ Ascentage Pharma Group Inc.
2018 -2019 Consultant @
2017 -2019 Member of the Board of Directors @ Osiris Therapeutics, Inc.
2018 -2019 Consultant @ Flex Pharma, Inc.
2015 -2017 General Counsel @ Galena Biopharma, Inc.
2010 -2015 EVP, Chief Legal Officer and Corporate Secretary @
2008 -2009 Partner @ Knapp Law Firm
2008 -2009 Of Counsel @
2003 -2008 Vice President General Counsel and Secretary @
1996 -2002 Of Counsel @
1998 -2000 Assistant General Counsel @
1980 -1995 Labor Counsel @ Burlington Northern and Santa Fe Railway Company
Thomas Knapp Education
Loyola University Chicago School of Law
JD (Law)
University of Illinois Urbana-Champaign
Bachelor’s Degree (Political Science)
Thomas Knapp Skills
Corporate Governance
Employment Law
Litigation
Mediation
Commercial Litigation
Arbitration
Administrative Law
Strategy
Public Policy
Government
Business Ethics
M&A experience
Commercial transactions
Strategic Planning
Compliance
Labor law
Regulatory Law
Management
Pharmaceutical Licensing
Global Strategy
Global Business Development
Global Licensing
Business Unit Start-up
Contract Management
Corporate Law
Public Speaking
Legal Writing
Research
Customer Service
Project Management
Business Development
Leadership
Thomas Knapp Summary
Thomas Knapp, based in Washington, DC, US, is currently a SVP, General Counsel at Ascentage Pharma Group. Thomas Knapp brings experience from previous roles at Ascentage Pharma, Ascentage Pharma Group Inc., Sellas Life Sciences and Osiris Therapeutics, Inc.. Thomas Knapp holds a JD in Law @ Loyola University Chicago School of Law. With a robust skill set that includes Corporate Governance, Employment Law, Litigation, Mediation, Commercial Litigation and more. Thomas Knapp has 1 emails on RocketReach.
Looking for a different Thomas Knapp?
Find contact details for 700 million professionals.